Interpace Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2010
Total Assets: $124.4M
Liabilities Breakdown FY2010
Total Liabilities: $54.9M
Asset Breakdown
Total Assets: $124.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $62.7M | 50.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $3.9M | 3.2% |
| Goodwill | $24.0M | 19.3% |
| Intangible Assets | $8.4M | 6.8% |
| Other Assets | $25.4M | 20.4% |
Liabilities Breakdown
Total Liabilities: $54.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.3M | 6.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $51.6M | 94.0% |